Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
833 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02583568 | Fluorescence Guided Surgery in Breast Cancer(MARGIN) | completed | Phase 1 / Phase 2 | 26 | University Medical Center GroningenOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT02519114 | Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma | unknown | Phase 1 / Phase 2 | 24 | Maastricht University Medical CenterOTHER | 1 | Feb 10, 2017 |
| NCT02718378 | Evaluation of Safety and Efficacy of Estetrol in Healthy Men | completed | Phase 1 | 45 | Pantarhei Oncology B.V.OTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT01471782 | Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | completed | Phase 1 / Phase 2 | 93 | Amgen Research (Munich) GmbHINDUSTRY | 7 | Feb 8, 2017 | clinicaltrials |
| NCT01929603 | Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours | completed | Phase 1 | 32 | AstraZenecaINDUSTRY | 2 | Jan 16, 2017 | clinicaltrials |
| NCT01469793 | A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer | completed | Phase 1 | 71 | Genentech, Inc.INDUSTRY | 2 | Jan 10, 2017 | clinicaltrials |
| NCT01690377 | Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients | completed | Phase 1 | 30 | Radboud University Medical CenterOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT00776698 | A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer. | completed | Phase 1 | 1 | Hoffmann-La RocheINDUSTRY | 2 | Nov 2, 2016 | clinicaltrials |
| NCT00975182 | A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors | completed | Phase 1 | 58 | Genentech, Inc.INDUSTRY | 2 | Nov 2, 2016 | clinicaltrials |
| NCT01358903 | A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors | completed | Phase 1 | 65 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT01383733 | A Study of RO5458640 in Patients With Advanced Solid Tumors | completed | Phase 1 | 54 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT01462175 | A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia | completed | Phase 1 | 99 | Hoffmann-La RocheINDUSTRY | 5 | Nov 2, 2016 | clinicaltrials |
| NCT01849666 | A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy | completed | Phase 1 | 2 | Hoffmann-La RocheINDUSTRY | 5 | Nov 2, 2016 | clinicaltrials |
| NCT01851824 | A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy | completed | Phase 1 | 9 | Hoffmann-La RocheINDUSTRY | 9 | Nov 2, 2016 | clinicaltrials |
| NCT02916992 | Prevalence of Spontaneous Pneumothorax in BHD | unknown | Phase 1 | 200 | Hans SmitOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT01894256 | Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function | completed | Phase 1 | 56 | AstraZenecaINDUSTRY | 5 | Oct 13, 2016 | clinicaltrials |
| NCT02033551 | A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors | completed | Phase 1 | 47 | AbbVieINDUSTRY | 3 | Sep 27, 2016 | clinicaltrials |
| NCT01046266 | A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma | completed | Phase 1 | 62 | Hoffmann-La RocheINDUSTRY | 5 | Sep 14, 2016 | clinicaltrials |
| NCT01777776 | Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. | terminated | Phase 1 / Phase 2 | 28 | Array BioPharmaINDUSTRY | 4 | Sep 13, 2016 | clinicaltrials |
| NCT01895946 | Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability(OAK) | completed | Phase 1 | 33 | AstraZenecaINDUSTRY | 2 | May 25, 2016 | clinicaltrials |
| NCT01705847 | A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies | completed | Phase 1 | 39 | Gilead SciencesINDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT00185081 | Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging | completed | Phase 1 | 42 | Radboud University Medical CenterOTHER | 1 | Apr 7, 2016 | clinicaltrials |
| NCT02221505 | Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia | terminated | Phase 1 | 3 | Novartis PharmaceuticalsINDUSTRY | 4 | Apr 5, 2016 | clinicaltrials |
| NCT01352338 | Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)(REPEAT) | completed | Phase 1 / Phase 2 | 82 | UMC UtrechtOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT01985191 | A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients | completed | Phase 1 | 26 | SanofiINDUSTRY | 2 | Feb 25, 2016 | clinicaltrials |
| NCT01637532 | Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer(PITCH) | completed | Phase 1 / Phase 2 | 21 | Leiden University Medical CenterOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT01162395 | Open Label Prostate Cancer Study | completed | Phase 1 | 64 | AstraZenecaINDUSTRY | 3 | Jan 12, 2016 | clinicaltrials |
| NCT00426556 | Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer | completed | Phase 1 | 88 | Novartis PharmaceuticalsINDUSTRY | 5 | Dec 28, 2015 | clinicaltrials |
| NCT00866281 | A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia | terminated | Phase 1 / Phase 2 | 22 | Novartis PharmaceuticalsINDUSTRY | 5 | Dec 22, 2015 | clinicaltrials |
| NCT01335269 | A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer | completed | Phase 1 | 96 | Boehringer IngelheimINDUSTRY | 2 | Dec 9, 2015 | clinicaltrials |
| NCT00546247 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) | terminated | Phase 1 / Phase 2 | 26 | Bristol-Myers SquibbINDUSTRY | 2 | Oct 12, 2015 | clinicaltrials |
| NCT01985295 | Combined Modality Treatment of Sarcomas of the Extremities(PASART-1) | completed | Phase 1 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT01090011 | Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer | completed | Phase 1 | 171 | Boehringer IngelheimINDUSTRY | 2 | Oct 2, 2015 | clinicaltrials |
| NCT00817518 | A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors | completed | Phase 1 | 145 | Hoffmann-La RocheINDUSTRY | 5 | Sep 2, 2015 | clinicaltrials |
| NCT00691548 | Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients(Cetuximab Zr89) | completed | Phase 1 | 9 | Maastricht Radiation OncologyOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00694837 | Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma | completed | Phase 1 | 6 | Maastricht Radiation OncologyOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT02395679 | Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients(MesoCancerVa) | unknown | Phase 1 | 9 | Erasmus Medical CenterOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT01582516 | Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma | completed | Phase 1 / Phase 2 | 20 | Erasmus Medical CenterOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01790451 | Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans | completed | Phase 1 | 16 | Clinical Research Office of the Endourological SocietyOTHER | 1 | Feb 20, 2015 | clinicaltrials |
| NCT01844869 | An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate | completed | Phase 1 | 6 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 1 | Jan 30, 2015 | clinicaltrials |
| NCT01386580 | An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. | completed | Phase 1 / Phase 2 | 84 | BBB-Therapeutics B.V.INDUSTRY | 4 | Jan 22, 2015 | clinicaltrials |
| NCT00704600 | Nelfinavir, a Phase I/Phase II Rectal Cancer Study(Nelfinavir) | completed | Phase 1 / Phase 2 | 15 | Maastricht Radiation OncologyOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT02298608 | Efficacy and Safety of IRE for RMs | unknown | Phase 1 / Phase 2 | 10 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01065623 | Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors | terminated | Phase 1 | 2 | BayerINDUSTRY | 1 | Oct 1, 2014 | clinicaltrials |
| NCT01392976 | Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | Clovis Oncology, Inc.INDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials